Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cellebrite DI Ltd. - Ordinary Shares (NQ: CLBT )

17.62 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 17.62
Bid (Size) 17.45 (4)
Ask (Size) 18.98 (1)
Prev. Close 17.62
Today's Range 17.62 - 17.62
52wk Range 10.24 - 26.30
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
5 Technology Names That Saw Brisk Retail Activity On Stocktwits Last Week
Earnings news has catalyzed frenzied activity in these stocks, and irrespective of the directional moves, sentiment toward them has remained uniformly upbeat. 
Via Stocktwits
Is This Stock a Next-Gen Digital Forensics Leader?
Via The Motley Fool

Performance

YTD
-18.65%
-18.65%
1 Month
-30.79%
-30.79%
3 Month
-13.59%
-13.59%
6 Month
+5.89%
+5.89%
1 Year
+53.08%
+53.08%

More News

Read More
The S&P 500 Fights Through Challenging Headlines To Close At New Weekly All-Time Highs
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
Cellebrite Announces Fourth-Quarter and Full-Year 2024 Results
From Cellebrite DI Ltd
Via GlobeNewswire
Earnings Scheduled For February 13, 2025
Via Benzinga
Cellebrite Government Cloud Platform Achieves FedRAMP High Ready Status
From Cellebrite DI Ltd
Via GlobeNewswire
Value of AI, Cloud Solutions Reign in Cellebrite’s 2025 Annual Industry Trends Survey
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite’s Generative AI Innovations Deliver a Powerful Assistant to Expedite Investigations
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite to Report Fourth-Quarter and Fiscal Year 2024 Financial Results on February 13, 2025
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite Announces Participation in the 27th Annual Needham & Company Growth Conference
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite Appoints Michael D. Capellas to Board of Directors as Lead Independent Director
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite Announces Participation in the UBS Global Technology and AI Conference
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite and Relativity Deliver Solutions to Transform the Mobile Data Collection Landscape
From Cellebrite DI Ltd
Via GlobeNewswire
CORRECTION: Cellebrite Announces Third-Quarter 2024 Results
From Cellebrite DI Ltd
Via GlobeNewswire
Yossi Carmil to Step Down as CEO After Nearly 20 Years
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite Announces Third-Quarter 2024 Results
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite Announces Tim Tebow as Keynote Speaker for Inaugural Case-to-Closure (C2C) User Summit 2025
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite to Report Third-Quarter 2024 Financial Results on November 6, 2024
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite Patents its Remote Mobile Collection Capabilities for Businesses
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite Announces Results of Completed Redemption of All Outstanding Warrants
From Cellebrite DI Ltd
Via GlobeNewswire
Cellebrite Enhances Investigative Analytics Solution with Amazon Web Services (AWS)
From Cellebrite DI Ltd; Amazon Web Services (AWS)
Via GlobeNewswire
Mailbag With Motley Fool Co-Founder Tom Gardner
Via The Motley Fool
Cellebrite Announces "Redemption Fair Market Value" in Connection with Redemption of All Outstanding Warrants
From Cellebrite DI Ltd
Via GlobeNewswire
H&R Block Posts Upbeat Earnings, Joins Alibaba Group, CI&T And Other Big Stocks Moving Higher On Friday
Via Benzinga
CLBT Stock Earnings: Cellebrite DI Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.